Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice

Recently, accumulating evidence has suggested that gut microbiota may be involved in the occurrence and development of ankylosing spondylitis (AS). It has been suggested that rifaximin have the ability to modulate the gut bacterial communities, prevent inflammatory response, and modulate gut barrier...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Cell Infect Microbiol
Main Authors: Yang, Lianjun, Liu, Bin, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Liu, Jinshi, Su, Zhihai, Wang, Min, Cui, Zhifei, Wang, Tingxuan, Zhang, Weicong, Li, Qingchu, Lu, Hai
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Cellular and Infection Microbiology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409347/
https://ncbi.nlm.nih.gov/pubmed/30886835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2019.00044
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki